Trial Profile
A large, US based, observational, real-world database, to identify clinical, demographic, and physician-related factors associated with women's adherence to Premarin® Vaginal Cream.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Nov 2017
Price :
$35
*
At a glance
- Drugs Conjugated estrogens (Primary)
- Indications Atrophic vaginitis
- Focus Therapeutic Use
- Sponsors Pfizer
- 27 Nov 2017 New trial record
- 14 Oct 2017 Results presented at the North American Menopause Society 2017 Annual Meeting